The US Food and Drug Administration is giving stakeholders another chance to submit comments on factors affecting the reprocessing of reusable medical devices1.
The FDA has reopened the opportunity to comment after stakeholders were unable to respond to a previous invitation for comments because the agency had omitted to activate the weblink that would allow them to do so...
Please Login to read the full article.
